Stockreport

Kiora Pharmaceuticals Receives European Orphan Medicinal Product Designation for KIO-301 for the Treatment of Inherited Retinal Dystrophies [Yahoo! Finance]

Kiora Pharmaceuticals, Inc.  (KPRX) 
PDF received Orphan Medicinal Product Designation from the European Medicines Agency (EMA) for the treatment of a group of inherited retinal diseases (IRDs) that include ret [Read more]